Taysha Gene Therapies Stock Price Prediction

TSHA Stock  USD 1.93  0.05  2.66%   
At this time, the RSI of Taysha Gene's share price is approaching 38. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Taysha Gene, making its price go up or down.

Oversold Vs Overbought

38

 
Oversold
 
Overbought
The successful prediction of Taysha Gene's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Taysha Gene Therapies, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Taysha Gene's stock price prediction:
EPS Estimate Next Quarter
(0.09)
EPS Estimate Current Year
(0.31)
EPS Estimate Next Year
(0.26)
Wall Street Target Price
6.5909
Quarterly Revenue Growth
(0.62)
Using Taysha Gene hype-based prediction, you can estimate the value of Taysha Gene Therapies from the perspective of Taysha Gene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Taysha Gene to buy its stock at a price that has no basis in reality. In that case, they are not buying Taysha because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Taysha Gene after-hype prediction price

    
  USD 2.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Taysha Gene Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.153.0611.66
Details
Naive
Forecast
LowNextHigh
0.052.6511.26
Details
11 Analysts
Consensus
LowTargetHigh
6.006.597.32
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.08-0.08-0.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Taysha Gene. Your research has to be compared to or analyzed against Taysha Gene's peers to derive any actionable benefits. When done correctly, Taysha Gene's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Taysha Gene Therapies.

Taysha Gene After-Hype Price Prediction Density Analysis

As far as predicting the price of Taysha Gene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Taysha Gene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Taysha Gene, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Taysha Gene Estimiated After-Hype Price Volatility

In the context of predicting Taysha Gene's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Taysha Gene's historical news coverage. Taysha Gene's after-hype downside and upside margins for the prediction period are 0.10 and 10.60, respectively. We have considered Taysha Gene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.93
2.00
After-hype Price
10.60
Upside
Taysha Gene is dangerous at this time. Analysis and calculation of next after-hype price of Taysha Gene Therapies is based on 3 months time horizon.

Taysha Gene Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Taysha Gene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Taysha Gene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Taysha Gene, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.28 
8.67
  0.08 
 0.00  
9 Events / Month
13 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.93
2.00
3.63 
3,211  
Notes

Taysha Gene Hype Timeline

Taysha Gene Therapies is at this time traded for 1.93. The entity has historical hype elasticity of 0.08, and average elasticity to hype of competition of 0.0. Taysha is forecasted to increase in value after the next headline, with the price projected to jump to 2.0 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 3.63%, whereas the daily expected return is at this time at 0.28%. The volatility of related hype on Taysha Gene is about 53813.79%, with the expected price after the next announcement by competition of 1.93. Taysha Gene Therapies currently holds 61.11 M in liabilities with Debt to Equity (D/E) ratio of 1.93, which is about average as compared to similar companies. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days.
Check out Taysha Gene Basic Forecasting Models to cross-verify your projections.

Taysha Gene Related Hype Analysis

Having access to credible news sources related to Taysha Gene's direct competition is more important than ever and may enhance your ability to predict Taysha Gene's future price movements. Getting to know how Taysha Gene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Taysha Gene may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BMEABiomea Fusion(0.30)11 per month 0.00 (0.23) 6.48 (11.36) 29.98 
STOKStoke Therapeutics 0.74 9 per month 0.00 (0.08) 5.57 (5.30) 27.59 
AKROAkero Therapeutics 0.15 10 per month 0.00 (0.03) 5.23 (4.35) 13.97 
FIXXFIXX Old(0.01)2 per month 3.52  0.03  5.77 (5.61) 19.43 
GOSSGossamer Bio(0.04)7 per month 3.02  0.01  6.06 (5.71) 36.21 
XFORX4 Pharmaceuticals 0.1 8 per month 10.59  0.07  26.42 (13.51) 67.48 
INZYInozyme Pharma(0.16)8 per month 0.00 (0.21) 6.41 (7.81) 16.32 
TERNTerns Pharmaceuticals 0.03 10 per month 0.00 (0.15) 5.17 (6.80) 26.61 
DAWNDay One Biopharmaceuticals(0.50)10 per month 0.00 (0.1) 3.03 (3.69) 11.05 
HOOKHookipa Pharma(0.01)8 per month 0.00 (0.28) 6.85 (6.67) 22.36 
GLUEMonte Rosa Therapeutics(0.33)9 per month 4.57  0.06  8.40 (8.46) 103.72 
CABACabaletta Bio(0.11)9 per month 0.00 (0.07) 10.83 (13.80) 43.64 
LRMRLarimar Therapeutics(0.02)9 per month 0.00 (0.13) 8.74 (10.56) 33.48 
ALECAlector(0.02)8 per month 0.00 (0.17) 6.94 (8.42) 42.73 
STTKShattuck Labs(0.02)8 per month 4.95  0.02  11.11 (9.01) 22.78 
CCCCC4 Therapeutics(0.02)9 per month 0.00 (0.07) 9.28 (8.28) 24.60 
ELYMELYM Old 0.25 4 per month 0.00 (0.23) 6.00 (9.35) 22.16 
PRLDPrelude Therapeutics(0.02)7 per month 0.00 (0.08) 11.20 (9.09) 55.77 

Taysha Gene Additional Predictive Modules

Most predictive techniques to examine Taysha price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Taysha using various technical indicators. When you analyze Taysha charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Taysha Gene Predictive Indicators

The successful prediction of Taysha Gene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Taysha Gene Therapies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Taysha Gene based on analysis of Taysha Gene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Taysha Gene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Taysha Gene's related companies.
 2022 2023 2024 2025 (projected)
Current Ratio1.544.084.694.45
Net Debt To EBITDA0.170.790.910.86

Story Coverage note for Taysha Gene

The number of cover stories for Taysha Gene depends on current market conditions and Taysha Gene's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Taysha Gene is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Taysha Gene's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Taysha Gene Short Properties

Taysha Gene's future price predictability will typically decrease when Taysha Gene's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Taysha Gene Therapies often depends not only on the future outlook of the potential Taysha Gene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Taysha Gene's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding116.1 M
Cash And Short Term Investments143.9 M

Complementary Tools for Taysha Stock analysis

When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges